Leach CL - Search Results

1

Inhalation aspects of therapeutic aerosols.

Leach CL. Leach CL. Toxicol Pathol. 2007 Jan;35(1):23-6. doi: 10.1080/01926230601072335. Toxicol Pathol. 2007. PMID: 17325969 Review.

2

Particle size of inhaled corticosteroids: does it matter?

Leach C, Colice GL, Luskin A. Leach C, et al. J Allergy Clin Immunol. 2009 Dec;124(6 Suppl):S88-93. doi: 10.1016/j.jaci.2009.09.050. J Allergy Clin Immunol. 2009. PMID: 19962042 Review.

3

Biologic comparison of inhaled insulin formulations: Exubera™ and novel spray-dried engineered particles of dextran-10.

Kuehl PJ, Cherrington A, Dobry DE, Edgerton D, Friesen DT, Hobbs C, Leach CL, Murri B, Neal D, Lyon DK, Vodak DT, Reed MD. Kuehl PJ, et al. Among authors: leach cl. AAPS PharmSciTech. 2014 Dec;15(6):1545-50. doi: 10.1208/s12249-014-0181-0. Epub 2014 Aug 9. AAPS PharmSciTech. 2014. PMID: 25106135 Free PMC article.

4

Alternative propellant aerosol delivery systems.

Smyth HD, Leach CL. Smyth HD, et al. Among authors: leach cl. Crit Rev Ther Drug Carrier Syst. 2005;22(6):493-534. doi: 10.1615/critrevtherdrugcarriersyst.v22.i6.10. Crit Rev Ther Drug Carrier Syst. 2005. PMID: 16566704 Review.

5

Two-dimensional and three-dimensional imaging show ciclesonide has high lung deposition and peripheral distribution: a nonrandomized study in healthy volunteers.

Leach CL, Bethke TD, Boudreau RJ, Hasselquist BE, Drollmann A, Davidson P, Wurst W. Leach CL, et al. J Aerosol Med. 2006 Summer;19(2):117-26. doi: 10.1089/jam.2006.19.117. J Aerosol Med. 2006. PMID: 16796536

6

Respiratory Tract Deposition of HFA-Beclomethasone and HFA-Fluticasone in Asthmatic Patients.

Leach CL, Kuehl PJ, Chand R, McDonald JD. Leach CL, et al. J Aerosol Med Pulm Drug Deliv. 2016 Apr;29(2):127-33. doi: 10.1089/jamp.2014.1199. Epub 2015 Jun 10. J Aerosol Med Pulm Drug Deliv. 2016. PMID: 26061801

7

Nasal Deposition of HFA-Beclomethasone, Aqueous Fluticasone Propionate and Aqueous Mometasone Furoate in Allergic Rhinitis Patients.

Leach CL, Kuehl PJ, Chand R, McDonald JD. Leach CL, et al. J Aerosol Med Pulm Drug Deliv. 2015 Oct;28(5):334-40. doi: 10.1089/jamp.2014.1180. Epub 2015 Feb 11. J Aerosol Med Pulm Drug Deliv. 2015. PMID: 25671692 Clinical Trial.

8

Characterization of respiratory deposition of fluticasone-salmeterol hydrofluoroalkane-134a and hydrofluoroalkane-134a beclomethasone in asthmatic patients.

Leach CL, Kuehl PJ, Chand R, Ketai L, Norenberg JP, McDonald JD. Leach CL, et al. Ann Allergy Asthma Immunol. 2012 Mar;108(3):195-200. doi: 10.1016/j.anai.2012.01.010. Ann Allergy Asthma Immunol. 2012. PMID: 22374204

9

A pilot study to assess lung deposition of HFA-beclomethasone and CFC-beclomethasone from a pressurized metered dose inhaler with and without add-on spacers and using varying breathhold times.

Leach CL, Colice GL. Leach CL, et al. J Aerosol Med Pulm Drug Deliv. 2010 Dec;23(6):355-61. doi: 10.1089/jamp.2009.0783. Epub 2010 Jun 24. J Aerosol Med Pulm Drug Deliv. 2010. PMID: 20575669

10

Influence of particle size and patient dosing technique on lung deposition of HFA-beclomethasone from a metered dose inhaler.

Leach CL, Davidson PJ, Hasselquist BE, Boudreau RJ. Leach CL, et al. J Aerosol Med. 2005 Winter;18(4):379-85. doi: 10.1089/jam.2005.18.379. J Aerosol Med. 2005. PMID: 16379614 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results